跳至主要内容
临床试验/IRCT20190826044619N1
IRCT20190826044619N1已完成1 期

Comparison of Aspirin dose (80 and 160 mg) in prevention of preeclampsia and maternal fetal complications

Iran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • The pregnant mother has completed the consent form to participate in the study.
  • Pregnant mother is 12 to 16 weeks pregnant.
  • The pregnant mother has at least one of the following criteria: a history of previous preeclampsia, polygamy, chronic hypertension, type 1 and type 2 diabetes, kidney disease, autoimmune disease (such as lupus). Or the pregnant mother has at least two of the following criteria: nulliparity, obesity, age over 35, low level of socioeconomic status, gap between pregnancies over 10 years, adverse pregnancy outcome (stillbirth, etc.)

排除标准

  • The pregnant mother has peptic ulcer.
  • The pregnant mother has gout.

研究者

相似试验